Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Drug Policies .

Tecelra® (afamitresgene autoleucel)

Niktimvo™ (axatilimab-csfr)

Actemra, Tofidence, Tyenne

Acthar Gel, Cortrophin Gel

Aloxi

Benlysta

Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu

Cerezyme® (imiglucerase)

Cimzia

Aralast NP; Glassia; Prolastin-C; Zemaira

Lucentis, Byooviz, Cimerli

Remicade, Inflectra, Renflexis, Avsola, Infliximab

Elelyso

Sandostatin LAR

Stelara, Wezlana, Selarsdi, Pyzchiva

Synagis® (Palivizumab)

Trelstar

Tysabri, Tyruko

VPRIV

Xolair